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 This study was looking at the factors that predicted an individual’s initial entrance 
into substance abuse treatment.  More specifically, this study looked at the influence 
between an individual’s demographics, preferred drug of choice and number of Interim 
Groups attended and how these factors related to the individual’s motivation to follow 
through with substance abuse treatment.  The participants in this study were individuals 
who were on local substance abuse treatment waiting lists. An analysis of the data was 
conducted using logistic regression. The statistical results indicated that demographics 
and preferred drug of choice were not predictive of an individual’s substance abuse 
treatment entry.  Factors such as the number of Interim Groups attended and the 
individual’s motivation and readiness for substance abuse treatment, as measured by the 
SOCRATES, were found to be significant, although they offered little predictive value 
regarding subsequent substance abuse treatment attendance.  Research and clinical 
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Introduction and Review of the Literature 
 One of the biggest challenges currently facing the field of substance abuse is that 
of individuals who have been referred for substance abuse treatment not continuing with 
the process to initiate this treatment.  In fact, research indicates that approximately 30% 
of individuals seeking treatment for substance abuse do not follow through (Donovan, 
Rosengren, Downey, Cox, & Sloan, 2001; Weisner, Mertens, Tam, & Moore, 2001).  
There are numerous explanations that could be used to help explain this lack of treatment 
follow through.  One such explanation is the limited availability of spaces in substance 
abuse treatment programs.  Typically when individuals cannot immediately enter into 
substance abuse treatment programs due to the lack of available spaces, or the lack of 
immediate public funding, they are placed on waitlists until a space in the treatment 
program or the funding becomes available. 
 Waitlists are a concern because it has been found that when a person is placed on 
a waitlist before treatment it decreases his or her motivation for following through with 
that referral (Miller, 1985).  Studies indicate that the longer individuals are on a waitlist 





et al., 2001).  Recent literature on the average waiting time for substance abuse treatment 
programs, as well as the average waiting time for publicly funded treatment, is scarce, 
and one of the only studies reporting average waitlist time periods is Brown, Hickey, 
Chung, Craig, and Jaffe (1989).  In this older study, looking at 42 cities throughout the 
United States, it was found that at least 75% of these cities had an average waiting time 
of 7-26 weeks for substance abuse treatment programs (U.S. Conference of Mayors as 
cited in Brown et al., 1989).  While these statistics are over 20 years old, and are 
referencing waitlists for substance abuse treatment in general and not just those 
individuals awaiting public funding, it is likely that these time periods are comparable to 
what an individual seeking substance abuse treatment would face today.  In Utah, in fact, 
in a 2007 Annual Report issued by the Utah Division of Substance Abuse and Mental 
Health, it was indicated that out of 95,058 individuals who sought substance abuse 
treatment in 2007, only 16,469 individuals were able to receive publicly funded substance 
abuse treatment (Utah Division of Substance Abuse and Mental Health, 2007).  These 
findings suggest that that the other 78,589 individuals were either placed on waitlists, had 
to pay for treatment on their own, or never followed through with receiving treatment.  
Additionally, even for those individuals who did receive publicly funded substance abuse 
treatment, it is likely that they were placed on a waitlist for a time period before receiving 
this treatment (Utah Division of Substance Abuse and Mental Health, 2007). 
 The aforementioned statistics help to emphasize the concern that substance abuse 
waitlists bring about, especially given that the goal is for individuals to initiate and follow 
through with substance abuse treatment.  Yancovitz et al. (1991) further illuminates the 





critical time for substance users who are looking for options to help change their 
behavior, and being on a waitlist means that they are most likely receiving no assistance 
during this time.  An assumption of waitlists is that individuals are expected to retain the 
motivation they have for receiving substance abuse treatment and initiate treatment when 
it becomes available. 
 Graham, Brett and Bois (1995) suggest individuals seeking substance abuse 
treatment are often ambivalent about changing their substance use behaviors.  They 
further indicate that this ambivalence could help to explain the high attrition rate in 
treatment programs as well as on waitlists.  Cellucci, Krogh and Vic (2006) elaborate on 
why individuals in need of substance abuse treatment may hesitate to receive that 
treatment.  They posit that oftentimes these individuals fail to recognize their substance 
use as problematic, or, if the individuals recognize the problematic behavior, they believe 
that they can change or reduce the problematic behavior on their own.  Following this 
logic, it seems likely that if an individual believes they can alter their behaviors on their 
own, they would be less likely to initiate substance abuse treatment after being placed on 
a waitlist.  Brown et al. (1989) found similar reasoning for individuals who became 
disillusioned while awaiting substance abuse treatment.  Brown et al. examined 
individuals who were on a waitlist for a residential program for cocaine abuse and found 
that the longer these individuals were on the waitlist, the less interested they became in 
receiving substance abuse treatment.  Moreover, they viewed the substance abuse 
program as being unable to meet their immediate needs and they became less confident in 
the program’s ability to provide them assistance at a later time.  Despite this research 





contemporary literature in the field. 
 In a study looking at individuals waiting to receive methadone treatment, Bell, 
Caplehorn and McNiel (1994) concluded that waitlists “deterred” individuals from 
entering treatment, and they were less likely to follow through with attending treatment 
after being placed on a waitlist.  Bell et al. offered no explanation of possible reasons for 
this deterrence, but Carr et al. (2008) suggested that individuals drop out of treatment 
prematurely due to a limited tolerance of being on a waitlist.  Additionally, they found 
that the longer an individual spends on a waitlist, the less readiness they have for 
treatment.  More specifically, Carr et al. posit that while individuals were likely to 
recognize their problematic substance behavior, and they desired to change that behavior 
by seeking treatment, being on a waitlist reduced their motivation to initiate treatment.  
Furthermore, Bell et al. (1994) suggest that these delays in the treatment admission 
process have an adverse effect on the individual’s engagement when they make it into 
treatment.  This suggests that waitlist delays make it more difficult to engage clients after 
treatment initiation. 
 With most substance abuse treatment programs having a waitlist of at least 1 
month or longer for admission to the program, it is of concern that these waitlists may act 
as a deterrent for an individual to enter the treatment that they desire and most likely need 
(U.S. Conference of Mayors as cited in Brown et al., 1989).  This then creates another 
challenge facing the field of substance abuse, which is discovering what helps individuals 
follow through with their recommended substance abuse treatment despite having to be 
placed on a waitlist.   





seeking substance abuse treatment, and being placed on waitlists, is that of motivation.  
According to Miller (1985), motivation is defined as an “acceptance and a surrender” to 
treatment, an expressed concern by the individual of his or her desire for help.  In 
applying this definition to an individual seeking substance abuse treatment, not only have 
they recognized their problematic substance use behavior, but they are expressing a 
desire to receive help to alter it.  Intuitively, the more motivation an individual has, the 
more likely he or she would be to follow through with a treatment recommendation, 
regardless of waitlist time.  Literature supports this postulation and indicates that higher 
motivation is related to an individual attending their first session of substance abuse 
treatment (DiClemente, Bellino & Neavins, 1999; Hiller, Knight, Leukefeld & Simpson, 
2002).  In fact, Joe, Simpson and Broome (1998) suggested that motivation not only 
helps predict that an individual will initiate treatment, but it also contributes to remaining 
in treatment. 
 Consistent with the aforementioned studies, Ryan, Plant and O’Malley (1995) 
discovered that a lack of motivation was one of the most frequently cited reasons for 
dropping out of treatment for adult alcoholics.  Miller (1985) describes motivation for 
substance abuse treatment as being that the individual has recognized that he or she is 
incapable of changing his or her situation on one’s own.  He suggests they are not in 
denial about having a problematic behavior, and they are not resisting getting help to 
change their behavior.  Applying Miller’s postulation to individuals who fail to initiate 
their substance abuse treatment, it would be likely that they have insufficient motivation 
for treatment.  They either deny having a problem, refuse to accept help to overcome 





consistent with the findings of Cellucci et al. (2006) that were previously mentioned. 
 Numerous studies have been conducted to help uncover what helps increase 
motivation for persons seeking substance abuse treatment.  Some researchers suggest that 
individuals experiencing negative consequences due to their substance use often become 
more motivated to participate in substance abuse treatment (Lozano, Stephens & 
Roffman, 2006;  Ryan et al., 1995).  In looking at the common characteristics of people 
seeking substance abuse treatment, Field, Duncan, Washington and Adinoff (2007) found 
that individuals are more likely to seek treatment and change their substance use if they 
have experienced significant negative consequences, such as a loss of a job, or emotional 
distress, such as relationship disturbances.  For example, if an individual perceives 
themselves as “hitting bottom,” defined as his or her perception of the negative 
consequences of their substance use, or if their use has caused a major lifestyle change, 
he or she will be more motivated to enter treatment and change (De Leon, Melnick & 
Kressel, 1997).   
 A common theme in the literature looking at what prompts individuals to begin to 
change their substance use patterns is, as De Leon et al. refer to it, “hitting bottom.”  
Cunningham, Sobell, Sobell and Gaskin (1997) evaluated the reasons for substance users 
to seek substance abuse treatment and determined that oftentimes “hitting rock bottom,” 
was what prompted these individuals to consider attending substance abuse treatment.  
Additionally, these individuals were more likely to follow through with their intention of 
attending substance abuse treatment, suggesting they are likely high in motivation for 
behavioral change.  Along the same lines, in a study looking at the role of motivation in 





that individuals with the highest level of motivation at treatment entry had often recently 
“hit bottom,” which they defined as suffering severe negative consequences and losing all 
that they have.  The findings of Rapp et al. suggest that oftentimes those with the highest 
motivation are those individuals with the most severe substance use problems.  While this 
could be the case, it appears the more important finding from Rapp et al. was their 
finding indicating that a person’s motivation for substance abuse treatment is often 
determined by the recognition of recent problems in his or her life.  This finding would 
suggest that whether or not an individual would be considered as having a severe 
substance use problem, the subjective awareness of the consequences of their use is the 
more important factor in determining their subsequent motivation. 
 Nwakeze, Magura and Rosenblum (2002) looked at a soup kitchen population of 
indigent individuals meeting criteria for substance dependence disorders, although not 
currently receiving treatment.  They found that the individuals with the greatest desire for 
help were those who had recently experienced negative consequences, such as physical or 
mental health issues or a loss of employment, due to their substance use and were 
therefore involuntarily forced to acknowledge the adverse effects of their addiction.  
Nwakeze et al. suggest these negative consequences helped to increase these individuals’ 
motivation for treatment.  Ryan et al. (1995) also postulate that experiencing adversities 
and consequences due to substance use can prompt individuals to develop a more 
intrinsic motivation, meaning these persons are likely to see their behavior as stemming 
from their own choices, and therefore, are more able to take accountability for their 
actions and their role in changing them.  Ryan et al. suggest this increased ability to take 





and complying with treatment once they begin it.   
As the aforementioned literature has demonstrated, combined with a lack of 
motivation to change, oftentimes individuals are not ready to change.  Readiness is 
defined as an individual’s preparedness to engage in treatment and to adopt new 
behaviors (DiClemente, Schlundt & Gemmell, 2004).  It has been found that not only is 
motivation a key factor in predicting a substance user remaining in treatment, but a user’s 
readiness for treatment also plays a key role in their seeking, complying with and 
remaining in treatment (Melnick, De Leon, Hawke, Jainchill & Kressel, 1997).  It could 
be posited that motivation and readiness are synonymous when looking at the key 
ingredients for successful initiation and follow through in substance abuse treatment. 
 For motivation and readiness to really exist, an individual must be able to 
recognize their problem, to search for ways to change their problem and to begin and 
stick with a change strategy (Dench & Bennett, 2000).  In other words, these men and 
women need to be ready to change and have to want to change their problem behavior.  
Several cognitive and affective processes have been identified that a substance user must 
go through before they are fully ready and committed to change (Carey, Purnine, Maisto 
& Carey, 1999).  The first of these processes is that the person experiences attitudinal 
shifts that reflect dissatisfaction with their substance use behavior, either in the behavior 
itself or the lifestyle that surrounds the behavior.  The person also becomes receptive to 
discuss the problems with their behavior and the possible negative consequences of 
continuing this behavior.  And finally, the person makes initial modifications to their 
behavior and continues to make changes until a new behavior is established. 





and retention of substance abuse treatment, it is important to consider the stages of 
change theory, or Trans-Theoretical Model.  This theory posits how an individual 
progresses through five stages of readiness to change during his or her substance abuse 
recovery (DiClemente et al., 2004).  Motivation is the key factor throughout the entire 
process of this change model, demonstrating that readiness for treatment and behavioral 
change are dependent upon an individual’s motivation (DiClemente et al., 2004).  
Prochaska, DiClemente and Norcoss (1992) have identified the following five stages of 
change: 1) Precontemplation, 2) Contemplation, 3) Preparation, 4) Action and 5) 
Maintenance.  During precontemplation the individual may be in denial or unaware of 
their problem, and there is no intent to change their behavior in the near future.  In the 
second stage, contemplation, the individual may be thinking about changing their 
behavior, he or she is aware that there is a problem with his or her behavior, but have not 
yet taken any concerted effort to change this behavior. During this time the person is 
likely weighing the pros and cons of their current behavior and in continuing or changing 
that behavior.  In preparation, the individual is making small changes to his or her 
behavior, they have made small reductions in their problem behavior and they intend to 
make more.  The fourth stage is action, where the person is committed to change and is 
taking the necessary action and effort to change the behavior; they may modify their 
environment to help them change his or her behavior.  The overt behavioral changes that 
take place during the action stage require substantial amounts of time and effort and a 
considerable amount of commitment.  The fifth and final stage is maintenance, where the 
individual maintains and continues the changes they have made in their problem behavior 





stages in a nonlinear fashion and may revisit several of the stages throughout their 
substance abuse recovery.  Although it should be noted that without motivation, a person 
is unlikely to progress very far in this stage model, and, in return, is unlikely to progress 
very far in treatment. 
 The stages of change authors posit the importance of recognizing a substance 
user’s readiness and motivation for change and targeting the treatment and interventions 
to the stage that the user is currently in (Prochaska et al., 1992).  This knowledge has 
implications for the use of waitlists and the subsequent lack of provided treatment during 
that time, and suggests that interventions should be targeted to those on waitlists to assist 
them in increasing their motivation and readiness for treatment.  As evidenced by 
Rohsenow et al. (2004), who performed assessments on individuals in cocaine abuse day 
treatment and found that those individuals espousing the precontemplation and 
contemplation stages of change were not as receptive to treatment interventions that 
would require action, or overt behavioral changes.  So while these individuals were 
participating in substance abuse treatment, they were likely not receiving the same 
benefits that an individual at a higher level of the motivation would gain from the 
intervention.  Furthermore, Rohsenow et al. suggest that those in the action stage of 
change may also experience deleterious effects if the treatment interventions are not 
specifically targeted to his or her stage of change. 
 Many interventions have been developed to help address the importance of 
targeting substance abuse interventions that match the individual’s motivation level.  The 
most notable of such interventions is that of Motivational Interviewing, which assists 





While literature suggests that Motivational Interviewing has numerous benefits, one of 
the key steps in the Motivational Interviewing process is allowing the individual to 
participate in what is called the ‘decisional balance,’ or the weighing of the pros and cons 
of retaining their substance use behaviors or of changing those behaviors (Miller & 
Rollnick, 2002).  Miller (1985) indicates this process helps to decrease the attractiveness 
of the substance using behavior by reducing the ambivalence of change, and makes it 
more likely that the client will move towards the action stage of change and start making 
changes.  As many of the previously mentioned studies have indicated, oftentimes people 
fail to initiate their substance abuse treatment because they are ambivalent about making 
changes in their substance use and other areas of their lives (Cellucci et al., 2006; 
Graham et al., 1995).  Given the predicament that waitlists create for such persons who 
are ambivalent about making changes in their lives, it would appear that Motivational 
Interviewing and similar interventions would help these people become more committed 
to change and more likely to comply with their substance abuse treatment 
recommendations. 
 A study conducted by German et al. (2006) explored individual’s motivation in 
discontinuing their methamphetamine use.  German et al. indicate that most individuals 
originally believed that their methamphetamine use was “controllable” and they were 
experiencing no negative consequences.  Applying the stages of change theory, these 
participants were precontemplative.  German et al. indicate that after having an 
opportunity to explore their substance use and the consequences, both negative and 
positive, these individuals were more likely to see benefit in ceasing his or her 





what Miller and Rollnick (2002) refer to as the decisional balance, where the person 
considers both the positive and negative of retaining or changing their behaviors.  These 
findings are consistent with other literature that states that problem recognition often 
helps individuals increase their motivation for behavioral change and substance abuse 
treatment (Fickenscher, Novins & Beals, 2006). 
 Horvath (1993) emphasizes the use of a cost-benefit analysis to help increase 
motivation in individuals seeking substance abuse treatment.  This cost-benefit analysis is 
comparable to Miller’s decisional balance and helps the individual to recognize the 
consequences of their substance use, while at the same time, enhancing the desirability of 
change.  Horvath (1993) believes the cost-benefit analysis helps to emphasize the 
individual’s reliance on their drug of choice and helps to highlight for them alternatives 
to using substances.  This process helps the person resolve some of the ambivalence they 
are experiencing as they begin to consider changing his or her behaviors, by allowing the 
person to identify the reasons for changing. As previously discussed, Nwakeze et al. 
(2002) found that the increased acknowledgement of the adverse effects of substance use 
can greatly increase an individual’s desire for treatment, which would also likely increase 
the likelihood that the individual moves into the contemplation or preparation stages of 
the stages of change.  This is further supported by Fiorentine and Hillhouse (2004), who 
looked at expectancies of individuals seeking treatment for substance abuse and found 
that experiencing negative consequences due to substance use can help move an 
individual from the precontemplation to contemplation stage.  Fiorentine and Hillhouse 
suggest that negative consequences make it difficult for an individual to retain positive 





these individuals to view treatment in a more positive light. 
 Whether or not individuals receive formal interventions to help them weigh the 
pros and cons of their substance use behavior, it appears likely that most individuals 
making the commitment to change their behavior and attend substance abuse treatment 
have, at some time, evaluated their reasons for change.  Share, McCrady and Epstein 
(2004) examined the decisional balance making process in a group of women seeking 
treatment for alcohol abuse.  The participants in the study of Share et al. were mostly 
found to be in the precontemplation, contemplation and action stages.  Share et al. 
juxtaposed data from individuals in the precontemplation stage with data from 
individuals in the action stage and demonstrated how individuals in the former stage are 
likely to have more perceived costs associated with changing their behavior compared to 
perceived benefits of change, whereas individuals in the action stage were more likely to 
have perceived benefits that greatly outweigh the perceived costs of changing their 
behavior.  These findings demonstrate that the stages of change theory is very much 
appropriate to the development of interventions in substance abuse treatment, which is 
important considering there appears to be a paucity of research that demonstrates the 
application of this theory in real world settings. 
 Another development that allowed clinicians, as well as researchers, to gain a 
better understanding of individuals seeking substance abuse treatment was the 
development of the Stages of Change and Treatment Eagerness Scales (SOCRATES).  
The SOCRATES, developed by Miller and Tonigan (1996), is used to measure the stages 
of change in individuals based on their scores on three scales, Taking Steps, Ambivalence 





demonstrates the use of the SOCRATES to evaluate the characteristics and behaviors of 
those seeking substance abuse treatment.  Gossop et al. conducted a longitudinal study 
looking at individuals initiating substance abuse treatment for illicit drugs and their 
subsequent treatment outcomes. Gossop et al. suggest that an individual scoring high on 
the Recognition scale is often associated with more frequent use of the illicit substances, 
as well as higher rates of anxiety and depression in the reporting individual.  The 
Recognition scale captures the awareness of negative consequences in the person’s life 
that have been caused by their use of substances, which Gossop et al. suggest that the 
more an individual uses substances, the more negative consequences they are likely to 
encounter.  Gossop et al. also suggest that higher scores on the Taking Steps scale are 
correlated with less frequent use of illicit substances, suggesting these individuals who 
are taking steps are more likely to decrease their substance use. 
 Cellucci et al. (2006) used the SOCRATES as a measure in their study looking at 
treatment seeking among problematic drinkers.  They determined that help seeking was 
positively correlated with higher scores on the Recognition scale, suggesting that 
individuals recognizing more problems due to their use are more likely to seek substance 
abuse treatment.  Furthermore, Dench and Bennett (2000) suggest the SOCRATES has 
implications for use to develop interventions to more effectively assist a client in their 
substance abuse recovery.  For instance, if a client is demonstrating ambivalence, the 
SOCRATES is likely to capture evidence of his or her ambivalence, and appropriate 
interventions can be implemented, such as the Motivational Interviewing technique of the 
decisional balance. 





easily assist clinicians and researchers, there is some debate about how well the 
SOCRATES captures the latent constructs that it claims to.  Maisto et al. (1999) suggest 
that the three-factor structure of the SOCRATES is relatively unstable, and that a two-
factor structure is more appropriate.  More specifically, Maisto et al. found that Miller 
and Tonigan’s Ambivalence and Recognition scales could be combined into one scale, 
AmRec, giving the SOCRATES two scales of AmRec and Taking Steps.  Maisto et al. 
attribute this change in SOCRATES structure to the fact that Miller and Tonigan’s 
norming sample was homogenous in terms of their substance use severity and other 
problems they were experiencing, giving rise to the three scales.  A study done by 
Burrow-Sanchez and Lundberg (2007) supported the findings of Maisto et al. and found 
that a modified 19-item version of the SOCRATES scale, containing the two factors of 
Ambivalence and Recognition (AMREC) and Taking Steps, was a better measure to fit 
the needs of an indigent adult population.  Furthermore, this study found that this 
modified scale was useful in a population where other drugs were abused in addition to 
alcohol. 
 Other critiques of the SOCRATES have focused not as much on the structure of 
the scale, but on how well the scales can capture client characteristics.  Caldwell (2002) 
suggests that individuals are more inclined to make changes in their behaviors before 
they are willing to acknowledge having a problem.  The scores on the SOCRATES for 
these individuals would therefore indicate that they are high on the Taking Steps scale but 
low on the Recognition scale.  Because of their high score on the Taking Steps scale, they 
would likely be considered in the action stage of change, although cognitively they may 





entering substance abuse treatment, as the client may not be as prepared for treatment as 
their SOCRATES scores suggest.  DiClemente, Doyle and Donovan (2009) also suggest 
that an individual expressing a readiness to change their substance use patterns is not the 
same thing as individual expressing a readiness for substance abuse treatment.  Given 
these findings, it would suggest that the SOCRATES be interpreted with careful 
consideration and assumptions about an individual’s readiness for substance abuse 
treatment should not be solely based on their scores. 
 Apart from considering the stages of change and other motivational and readiness 
factors, different client characteristics may play a role in the individual’s follow through 
with their substance abuse treatment referral.  Given the pervasiveness of motivation and 
readiness on other personal characteristics, it is difficult to completely separate out the 
effects of these personal factors with the effects of motivation and readiness, although 
there is some literature with compelling evidence suggesting otherwise.  Despite evidence 
that client demographics and background are not consistent predictors of substance abuse 
treatment retention, other literature suggests that these client characteristics offer unique 
contributions and play an important role in determining if an individual will follow 
through with a substance abuse treatment referral (De Leon et al., 1997).   
 One study that analyzed a database of individuals seeking treatment for marijuana 
dependence found that being younger, unmarried, unemployed, less education and non-
white were correlated with prematurely dropping out of substance abuse treatment 
(Vendetti et al., 1997).  Given the individual characteristics discussed by Vendetti et al., 
it could be posited that these individuals fail to initiate treatment due to exhibiting more 





and fewer social and occupational obligations.  Brecht, Greenwell and Anglin (2005) also 
found that a lower educational achievement and a younger age were correlated with 
individuals being less likely to initiate substance abuse treatment for methamphetamine 
abuse.  Thompson, Hunt and Issakidis (2004) obtained self-reports from individuals 
regarding their reasons for delaying their substance abuse treatment.  Findings of this 
investigation indicate that oftentimes a fear of stigma associated with receiving mental 
health counseling provide justification for not seeking substance abuse treatment.  
Thompson et al. also discovered that many individuals admitted to delaying seeking 
treatment for an average of 8 years after they began to notice negative consequences due 
to their substance use.  The findings of Thompson et al. could give some interpretation to 
the findings of Vendetti et al. and Brecht et al. by suggesting that younger individuals 
could be delaying their treatment seeking due to either perceived stigma associated with 
substance abuse treatment or not recognizing the problematic nature of their substance 
use.   
Another demographic variable that is frequently researched in the substance abuse 
field is that of legal referral to substance abuse treatment.  Weisner et al. (2009) looked at 
a sample of individuals who were mandated by their employer to receive substance abuse 
treatment and compared these individuals to those who were voluntarily seeking 
substance abuse treatment.  They concluded that those individuals mandated to receive 
substance abuse treatment had similar outcomes to those who were receiving treatment 
voluntarily.  Weisner et al. also discovered that oftentimes the individuals mandated to 
receive treatment were less motivated than those who were voluntarily, but this 





treatment.  Stevens et al. (2006) found similar results in that individuals who are legally 
referred to complete substance abuse treatment did not differ much from individuals who 
were voluntarily seeking substance abuse treatment.   Interestingly, De Leon, Melnick, 
Kressel and Jainchill (1994) found that the most consistent predictor of retention in 
substance abuse treatment was legal referral, with individuals who are legally referred 
averaging more days in treatment than those individuals with voluntary admission at a 
30-day follow-up. As these studies demonstrate, there is some discrepancy in the 
literature about the significance of various demographic characteristics and their role in 
an individual seeking and completing substance abuse treatment. 
 Aside from considering demographic characteristics, much attention has been 
given to attempting to determine differences between individuals endorsing various 
primary drugs of choice, and how they relate to an individual’s likelihood of initiating 
substance abuse treatment.  De Leon et al. (1997) found that there were no significant 
differences amongst the different drugs of choice in reference to the individual’s 
motivation and readiness for treatment, or in the individual’s overall retention in the 
substance abuse treatment program.  De Leon et al. posited these findings indicate that 
treatment interventions should target personal attributes (i.e., motivation and readiness) 
and give less focus to differential treatment of drugs of choice (i.e.,  proclamations that 
one substance is more addictive than another substance).   
 While De Leon et al. (1997) suggest there is no difference in treatment attendance 
amongst the users of different drugs of choice, other literature suggests otherwise.  
Weisner et al. (2001) suggest that individuals seeking substance abuse treatment for 





treatment for other drug dependencies.  Weisner et al. attributed this difference to 
differing motivation levels, although they did not discuss other factors that could be 
contributing to this difference.  In contrast, Sinha, Easton, Renee-Aubin and Carroll 
(2003) examined probation-referred individuals seeking substance abuse treatment for 
marijuana use and found that individuals specifying marijuana as their drug of choice are 
less likely to return and initiate their substance abuse treatment than individuals 
endorsing other drugs of choice.  Sinha et al. additionally indicate that individuals 
endorsing marijuana as their drug of choice have lower motivation to change their 
substance use and to attend treatment, and are more likely to be in the precontemplation 
stage of change, than individuals endorsing other drugs of choice. 
 Stephens et al. (2004) and Stephens, Roffman, Fearer, Williams and Burke (2007) 
also support the findings that individuals specifying marijuana as their drug of choice are 
typically under-represented in the substance abuse treatment population.  Stephens et al. 
(2007) suggest this underrepresentation is due to marijuana users not being able to afford 
treatment, not being ready to stop using marijuana and a fear of stigma associated with 
receiving substance abuse treatment.  While these are compelling reasons for not 
initiating substance abuse treatment, Budney, Radonovich, Higgins and Wong (1998) 
suggest that marijuana users are more ambivalent about changing their substance use and 
are less confident in their ability to stop using marijuana when compared with individuals 
seeking substance abuse treatment for cocaine use.  Budney et al. also highlights that the 
lifetime prevalence for marijuana dependence is highest of all the illicit drugs, making it 
of concern that these individuals have the lowest representation in substance abuse 





abuse treatment for marijuana use are more ambivalent about receiving treatment because 
they are likely to feel that their substance problem is different from that of other illicit 
drugs, and are more likely to believe that the available treatment will not be beneficial.  
This study also suggests that marijuana users are less likely to experience some of the 
significant negative consequences that users of other drugs may experience (i.e., 
overdose, severe physical addiction) and therefore are less likely to see a substantial need 
for receiving substance abuse treatment.  Interestingly, individuals espousing marijuana 
as their primary drug of choice are more likely than individuals indicating alcohol as their 
primary drug of choice to report a secondary or tertiary problematic substance, making it 
a larger concern that these individuals are often underrepresented in the treatment 
population (Urbanoski, Strike & Rush, 2005). 
 In looking at factors that prompt an individual to seek substance abuse treatment, 
Ross et al. (2005) suggest that individuals are likely to be experiencing health-related 
concerns.  They examined various characteristics of individuals seeking substance abuse 
treatment for heroin dependence and found that individuals experiencing complications 
due to injecting the substance or overdosing on the substance were more likely to seek 
treatment than individuals who had not experienced these complications.  Neale and 
Robertson (2005) found similar results when looking at individuals seeking substance 
abuse treatment for heroin addiction.  Many participants in this study reported 
experiencing at least one overdose in the 90 days prior to their treatment entry.  
Additionally, the individuals who had recently experienced overdoses were more likely to 
have used other substances in addition to heroin, such as cocaine and amphetamines.  





abuse treatment, health concerns were a more important determining factor in 
successfully initiating substance abuse treatment than that of legal referral or other 
demographic characteristics. 
 These findings on the differential rate of treatment seeking for users of various 
drugs of choice illustrate the previously mentioned idea that the acknowledgment of the 
negative consequences of substance use and the increased problem recognition can 
motivate individuals to seek substance abuse treatment.  These findings also suggest that 
if an individual is not experiencing acute, negative effects from their substance use they 
are likely to not seek substance abuse treatment.  For example, Proudfoot and Teesson 
(2002) discovered that many individuals with alcohol dependence do not perceive 
themselves as having a significant problem that would require treatment.  This finding 
could be attributed to the social acceptability of alcohol use, and the failure of individuals 
to recognize their alcohol use as problematic because others they know also drink.  
Similarly, Agostinelli, Floyd, Grube, Woodall and Miller (2004) conducted a study on 
undergraduate students at a university and determined that individuals are likely to 
compare the amount of alcohol they consume with the amount of alcohol they perceive 
others as consuming.  As a result, if an individual sees others consuming more alcohol 
than they do, they are less likely to believe that their own use is problematic. 
 In consideration of the available literature and theories discussing behavioral 
changes, it would appear that the field of substance abuse needs to more efficiently 
overcome the challenges that the use of waitlists creates for individuals placed on them.  
While several methods and interventions have been suggested, one intervention gaining 





attend while they are awaiting substance abuse treatment.  There is presently a paucity of 
literature on the use of interim groups and similar interim strategies, although the 
evidence from the available literature appears promising.  One such study was looking 
individuals seeking treatment for heroin dependence (Schwartz et. al., 2006).  Schwartz et 
al. evaluated individuals who were given an interim treatment of methadone versus 
individuals who were placed on a waitlist without receiving any interim assistance or 
attention until their entry to treatment.  Findings indicate that the individuals who 
received the interim methadone were not only more likely to attend treatment than those 
solely on the waitlist, but the individuals receiving methadone were also more likely to 
reduce their use of heroin and avoid criminal behaviors.  Schwartz et al. concludes that 
some of these findings could be attributed to the methadone individuals receiving case 
management, which served as additional support as they awaited their admission to 
treatment. 
 Highfield, Schwartz, Jaffe and O’Grady (2007) also looked at individuals 
receiving interim methadone treatment while awaiting substance abuse treatment and 
found similar results to those of Schwartz et al., such as a decrease in substance use and a 
higher rate of initiation to treatment.  In the study conducted by Highfield et al., no 
psychosocial services were offered in the interim between initial contact and treatment 
entry, although the individuals had limited contact with supportive others while obtaining 
their methadone.  Similarly, a study conducted by Yancovitz et al. (1991) looked at 
individuals on a waitlist to receive methadone maintenance.  This study found that 
participating in interim groups allowed these individuals to decrease their use of heroin, 





individuals that Yancovitz et al. investigated also received limited services that helped to 
educate the potential clients as well as limited counseling services that were conducted in 
an informal manner.  Individuals in this study participated in interim services for 
approximately one month before their entry into treatment.  Criticism about the interim 
services studied by Yancovitz et al. suggest that these services do not address social and 
vocational needs that are pertinent to individuals seeking substance abuse treatment.  
Yancovitz et al. respond to this criticism by suggesting these interim services provide a 
benefit to individuals awaiting treatment, and the lack of specific services does not appear 
to make a significant difference.  Goehl, Nunes, Quitkin and Hilton (1993) suggest that 
social support plays a key factor in successfully initiating and completing substance 
abuse treatment.  This finding would suggest that individuals, such as those studied by 
Yancovitz et al., who are around and interacting with others in their similar situation are 
likely to gain more social support and increased subjective well-being than individuals 
who do not have these interpersonal connections. 
 In another study looking at interim strategies to support individuals awaiting 
substance abuse treatment, Ravarino, Gardner, Hill and Lundberg (2008) looked at 
methamphetamine users who were attending pretreatment Interim Groups as they waited 
for treatment.  The Interim Groups in the study conducted by Ravarino et al. were 
different from the services discussed in the previous studies, and these groups more 
comparable to pretreatment support groups that are readily available for individuals 
awaiting substance abuse treatment.  Ravarino et al. found that attending between 5 and 
24 of these groups helped to predict the user’s later attendance in treatment, and that 





attendance.  In these groups, a motivational interviewing philosophy was used to help 
encourage increased motivation in these treatment seekers. 
 The findings of Ravarino et al. (2008) suggest that Interim Groups can help to 
increase the likelihood that methamphetamine users will initiate substance abuse 
treatment.  Interim Groups serve as a way for abusers who are waiting for substance 
abuse treatment to gain support for changing their behavior and also gain strategies to 
help facilitate that change.  This evidence suggests that these groups are beneficial for 
methamphetamine users, indicated by the more Interim Groups that the substance user 
attends, the more likely that he or she will attend treatment (Ravarino et al., 2008).  More 
research needs to be conducted to see if this same effectiveness applies to users of other 
drugs, such as alcohol, marijuana, cocaine and heroin.   
 
Limitations of the Available Research 
 The current literature in the field addresses numerous aspects of the differential 
rates of treatment seeking among individuals with preferences for different drugs of 
choice, as well as from different demographic backgrounds.  The available research also 
addresses the imminent danger of using waitlists and the subsequent failure of treatment 
initiation.  Additionally, this literature expresses the importance of exploring ambivalence 
and improving motivation, although this task is often daunting to complete while 
individuals are on waitlists.  In evaluating the current literature in the field, there appears 
to be a paucity of research addressing how motivation fluctuates from initial treatment 
seeking to the actual initiation of therapy, and what personal factors are likely to 





Purpose of the Present Study 
 The purpose of the current study is to look at the factors that predict an 
individual’s initial entrance into treatment.  Specifically the influence between that of 
demographics, an individual’s preferred drug of choice, their attendance at Interim Group 
and how they relate to that individual’s motivation to follow through with substance 
abuse treatment, as measured by the scores on the SOCRATES scales.  Research 
questions: 1) Will primary drug of choice predict entrance into treatment?  2) Will the 
SOCRATES scales (Ambivalence, Recognition and Taking Steps) be a better predictor of 





















 The participants in this study were individuals referred for substance abuse 
treatment and were seeking publicly funded substance abuse treatment in a medium-sized 
city in a Mountain West State.  They had been referred to attend Interim Groups through 
the Interim Group Services (IGS) program while awaiting admission to substance abuse 
treatment programs.  The participants attended Interim Groups from April 1, 2006 
through April 1, 2007.  Only individuals reporting alcohol, methamphetamine, heroin, 
cocaine or marijuana as their primary drugs of choice were considered, as these were the 
largest reported categories for primary drug of choice.  These Interim Group attendees 





 Interim Group Services (IGS) are offered 6 days per week and all individuals 




group.  These groups help to provide support and guidance to individuals who are 
preparing to enter substance abuse treatment.  They are conducted using a Motivational 
Interviewing philosophy, harm reduction education is provided when needed and group 
support is emphasized.  Ideally participation in Interim Group helps to build on the 
individual’s autonomy, and encourage them to find their own resources for change by 
using their internal motivation to change their behavior. The group support allows the 
individual to receive encouragement and help from other group members and there is also 





 A modified version of the SOCRATES was administered each time the individual 
attended an Interim Group to assess how much the individual believed they had a 
problem with drugs or alcohol and if they perceived a need to change their behavior 
(Miller & Tonigan, 1996; See Appendix A).  For this study, completed SOCRATES 
information from April 1, 2006 to April 1, 2007 was used and only the SOCRATES 
completed at the individual’s first Interim Group attendance was evaluated.  Participants 
completed a 27-item questionnaire where they were instructed to use a 5-point scale to 
state how much they agree with the statements ( 1= strongly disagree, 2= disagree, 3= 
neutral, 4= agree and 5= strongly agree).  Before answering these statements, participants 
were instructed to complete personal information including stating their primary drug of 




themselves on a 5-point scale whether they came to Interim Group by choice, with one 
being ‘not at all,’ three being ‘somewhat’ and five being ‘totally.’  This questionnaire 
also contained a section asking the participant if this was the first Interim Group that they 
had attended.  For participants who had attended interim groups before, the questionnaire 
asked how many days it had been since the last Interim Group attended and how many 
days since last coming to Interim Group that they used alcohol or drugs.  This 
questionnaire was adapted from Miller and Tonigan’s (1996) 19-item SOCRATES to use 
in the Interim Group setting; therefore, some wording was changed to better capture the 
motivation of those not reporting alcohol as their drug of choice, as well the addition of 
eight items from the University of Rhode Island Change Assessment (URICA). While 
developing the SOCRATES, Miller and Tonigan (1996) obtained normative data in an 
outpatient setting and the measure was normed on a largely White, male population with 
an average age of 38 years old.   
 The SOCRATES measures the five stages of the Transtheoretical stages of 
change model, assessing the individual’s motivation in the different stages (Miller & 
Tonigan, 1996).  The SOCRATES is used to assess the individual’s acknowledgement of 
an alcohol or drug problem and their perceived need to change to change his or her 
drinking or drug use.  The SOCRATES contains three subscales: 1) Taking Steps, 2) 
Recognition and 3) Ambivalence.  Taking Steps addresses the Action and Maintenance 
stages of the stages of change theory, examing the changes that individuals are making to 
alter their problem behavior.  The Recognition scale addresses the awareness users have 
of the problems that are caused by their substance use. And finally, the Ambivalence 




drug use, similar to the Contemplation stage in the stages of change theory (Miller & 
Tonigan, 1996).   
 In scoring the SOCRATES, a score of below 15 is preferable on the Ambivalence 
scale, as this scale is reverse-scored, and a lower score is suggestive of individuals being 
aware of the negative consequences due to their substance use.  A score of above 33 on 
the Recognition scale is preferable and indicates individuals acknowledge they are 
experiencing negative consequences due to their substance use and are expressing a 
desire to change that behavior.  A score of above 33 on the Taking Steps scale is also 
preferable and indicates the individual is making changes in substance use behaviors.  
 
Demographics 
 Demographic information was collected the first time the individual attended an 
Interim Group (See Appendix B).  This information included the substance abuser’s age, 
race, ethnicity, education level completed, employment status, military services, marital 
status, who referred him or her to the agency and who needed to know that he or she was 
attending Interim Groups.  This information also included the substance abuser’s drug 
use history, including their drug of choice, how often they used that or other drugs, how 
they administered their drugs, how long they had been using drugs, if they had received 
substance abuse treatment in the past, if they were pregnant or had miscarried, if they 
were HIV positive, any psychological diagnoses they were aware they have, the number 
of children they have, the number of arrests they had in the past 6 months, their current 
living situation, their current health insurance status, the age at which they first used 




not the individual was currently participating in any other support groups, such as 
Alcoholics Anonymous.  All of the information on this sheet was for program evaluation 




An analysis of the data was conducted using logistic regression.  In this model the 
dependent variable being measured was whether or not the participant attended treatment 
(‘yes’ or ‘no’), with a ‘yes’ response indicating if the individual attended the first day of 
substance abuse treatment.  The 1st day of substance abuse treatment was considered 
attending treatment if it occurred within 1-190 days after admission at Interim Group 
Services.  This time period was chosen based on the findings from Ravarino et al. (2008) 
which indicated most IGS clients could have been admitted to substance abuse treatment 
within 190 days.  The predictor variables contain demographic information (e.g., sex, 
age, race, ethnicity, educational level, marital status and employment status), the type of 
drug the individual reported as being his or her primary drug of choice, the individual’s 
reported motivation as reported in the scales of the SOCRATES questionnaire, and the 
number of Interim Groups the individual attended.  These predictor variables were used 
to determine the percentage of variance that could be explained in the dependent variable 
and helped rank the relative importance of the different independent variables 
(Tabachnick & Fidell, 1996).  Logistic regression helps to estimate the likelihood of a 
certain event occurring, so in the case of the present study, helping to predict which 




helped to demonstrate how likely the observed values of the dependent variable can be 
predicted from the observed values of the independent variable.  The goal of logistic 
regression is to correctly predict the category of outcome for individual cases, so whether 
or not the participants make it to treatment.  This method of analysis provided knowledge 













 This study originally consisted of 2,096 participants from an extant dataset of a 
community sample of individuals seeking substance abuse treatment services.  Participant 
demographic data were matched with available SOCRATES data, which resulted in the 
elimination of 906 participants who did not provide SOCRATES data.  Reasons for these 
participants not providing SOCRATES data are unknown.  Furthermore, only participants 
specifying alcohol, marijuana, methamphetamine, cocaine and heroin as his or her 
primary drug of choice were considered in this study, and participants specifying other 
drugs of choice were eliminated.  Since this study is replicating the study conducted by 
Ravarino et al. (2008), the present study focused only on variables that were considered 
in the previous study, and all other variables were eliminated.  Additionally, 395 
participants were eliminated because they were missing at least half of demographic data 
or the SOCRATES data and another 22 participants were eliminated as outliers in various 
demographic or SOCRATES categories.  This resulted in a final dataset consisting of a 
sample of 773 participants with complete information on demographic and SOCRATES 




 Descriptive Statistics 
 Descriptive statistics were calculated for the final sample of 773 participants in 
this study.  The descriptive statistics for this sample included means and standard 
deviations (or frequency analysis) for the following variables: admission to treatment, 
sex, referral source, employment status, racial background, ethnic background, marital 
status, level of education, number of interim groups attended, drug of choice, frequency 
of substance use and SOCRATES scales.  Results from the descriptive statistics indicated 
that the participants in this sample were largely male (69.7%), White (78.5%) and 
unemployed (60.4%) and the mean age of the population was 33.65.  Only 40.4% of 
participants attended the 1st day of substance abuse treatment, indicating that the majority 
of the sample (59.6%) did not initiate their recommended substance abuse treatment.  
More specific descriptive statistics for this sample are summarized in Table 1. 
 Descriptive statistics also indicated that the sample was largely composed of 
methamphetamine users (34.3%) who had not used the drug in the 30 days prior to their 
admittance at Interim Group Services (IGS) (47.0%).  These results are summarized in 
Figure 1 and Figure 2. 
 A descriptive analysis of the SOCRATES scales illustrates that the majority of 
the study sample had low problem Recognition, low Ambivalence and were at varying 
levels of Taking Steps.  An interpretation of the SOCRATES scale scores is presented in 







Logistic Regression – Research Question #1 
Will primary drug of choice predict entrance into treatment? 
 Data were examined prior to analysis following these steps:  A preliminary linear 
regression was conducted to examine multicollinearity and to calculate Mahalanobis’ 
Distance.  Results from this analysis indicated that multicollinearity was not a problem.  
Results indicated that no outliers were identified as exceeding the Chi Square cutoff 
criteria, and, therefore, no participants were eliminated.  SPSS identified 43 cases as 
missing drug of choice data, resulting in 730 participants in this analysis. 
 A binary logistic regression was then performed on data for 730 participants.  In 
order to examine the contribution of each category of the drug of choice variable, the 
Enter method was selected and the treatment variable was used as the dichotomous 
dependent variable (0= no treatment attendance and 1= treatment attendance). The drug 
of choice variable was entered into the model using the indicator contrasting method and 
used the first category, or Alcohol, as the reference category that the other drugs were 
compared against.  Alcohol was used as reference category because it was the second 
largest category of primary of drug of choice and appeared to include a reasonable 
number of participants in which to compare the other drug of choice categories to.  The 
results of this analysis are summarized in Table 4. 
 None of the predictor variables were significant.  The nonsignificance was 
supported by a general lack of model fit as evidenced by large model fit indices (-2 Log 
Likelihood= 983.716) which indicated that drug of choice was a poor fitting model for 
predicting substance abuse treatment entry.  In logistic regression, the lower the value of 




Vannatta, 2005).  The Chi-Square statistics (χ2 (4)= 5.004, p<.287) further demonstrate 
that this model does not significantly predict group membership.  In addition to the model 
not being a good fit, the model was only slightly more than chance in classifying subjects 
and predicting group membership, with an overall classification percentage of 61.7%.  As 
can be seen in Table 4, none of the drugs of choices were significant predictors of 
substance abuse treatment entry, although marijuana appeared to be approaching 
significance.  This indicates marijuana users may be less likely to attend substance abuse 
treatment than alcohol users, but the small odds ratio of .624 did not provide much 
additional information on marijuana’s ability to predict substance abuse treatment entry.  
 Table 5 further details the admission to treatment by drug of choice.  As can be 
seen in this table, while each drug of choice varied slightly in the percentage of 
individuals who made it to treatment, no one drug appeared to have significantly higher 
rates of treatment attendance.  Further, each drug of choice had more individuals not 
attend treatment than attended treatment. 
 
Logistic Regression – Research Question #2 
Will the SOCRATES scales (Ambivalence, Recognition and Taking Steps) be a better 
predictor of entrance into treatment compared to that of demographics or number of 
Interim Groups attended? 
 Data were examined prior to analysis following these steps:  A preliminary linear 
regression was conducted to examine multicollinearity and to calculate Mahalanobis’ 
Distance.  Results from this analysis indicated that multicollinearity was not a problem 




the Mahalanobis Distance test indicated that the data contained 22 outliers according to 
Chi-Square cutoff criteria (χ2 (13, N=773) = 22.36, p<.05).  As previously discussed in 
the dataset section, these 22 participants were identified and eliminated, resulting in a 
population of 773 in this analysis.   
 Hierarchical logistic regression was performed on the data using the Enter 
method, which forces the entry of all variables into the equation regardless of their 
significant contribution, in order to examine the contribution of each variable.  In this 
analysis, the treatment variable was the dichotomous dependent variable (0= no treatment 
attendance and 1= treatment attendance), and the independent variables were entered into 
the analysis in a series of six blocks.  All of the independent variables were entered into 
the model using the indicator contrasting method and used the first category as the 
reference category.   
 The logistic regression results are summarized in Table 6.  The results indicate 
that the Interim Group and the Taking Steps scale of the SOCRATES were significant, 
and no significant predictors were found in the first four blocks of this model.  More 
specifically, Interim Group was found to be a significant predictor of attending substance 
abuse treatment for all three levels of this variable.  Results indicate that the odds of 
attending substance abuse treatment decreased with an increase in the number of Interim 
Groups attended.  This is evidenced by a decrease in the odds of attending treatment for 
participants who attended 2-4 Groups (B=-.56, p<.003, 95% C.I.=.391-.824) by a factor 
of .568 and a decrease in the odds of attending treatment for participants who attended 5 
or more Groups (B=-.418, p<.038, 95% C.I.=.444-.976) by a factor of .658 compared to 




significant, the small odds ratios suggest that this variable offers little predictive value 
and it is difficult to interpret its impact on predicting substance abuse treatment. 
 The Taking Steps scale of the SOCRATES was also found to be a significant 
predictor of attending substance abuse treatment.  Results indicate that higher scores on 
the Taking Steps scale (B= .034, p<.041, 95% C.I.= 1.001-1.069) were more predictive of 
attending substance abuse treatment than were scores on either the Recognition scale or 
the Ambivalence scale.  More specifically, results indicate that as a participant’s scores 
increased by one-unit on the Taking Steps scale, their odds of attending substance abuse 
treatment increased by a factor of 1.035.  As previously mentioned with the Interim 
Group results, the small size of the Taking Steps odds ratio suggests it offers little 





























 Descriptive and Frequency Statistics 
Variable Categories Frequency % of Sample 
    





    





    





    





    





    





    





    
Level of Education 
Less Than High School 
High School Diploma or GED 
Some College or Voc Training 























Note:  Non-White = American Indian, Asian American, African American and Pacific 
Islander  
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 SOCRATES Scales Interpretation 
Variable Very High High Medium Low Very Low 
      
Recognition N/A 34-35 31-33 27-30 7-26 
      
Ambivalence 18-20 16-17 14-15 9-13 4-8 
      
Taking Steps 37-40 34-36 31-33 26-30 8-25 
      







 SOCRATES Scales Descriptive Statistics 
Variable N Minimum Maximum Mean SD 
      
Recognition 773 7 35 28.29 6.807 
      
Ambivalence 773 4 20 12.56 3.982 
      
Taking Steps 773 8 40 33.79 5.666 
      















 Logistic Regression Analysis of Drug of Choice Variable Influencing Treatment 
Attendance 
Predictor Variable B Wald d.f. p Odds Ratio 
      
Alcohol  4.892 4 .299  
      
Cocaine -.080 .091 1 .763 .923 
      
Marijuana -.471 3.526 1 .060 .624 
      
Heroin .112 .183 1 .669 1.118 
      
Methamphetamine -.126 .411 1 .522 .882 
      
Constant -.248 2.705 1 .100 .780 
      










Predictor Variable Yes (%) No (%) N 
    
Alcohol 43.8 56.2 178 
    
Cocaine 41.9 58.1 86 
    
Marijuana 42.5 57.5 87 
    
Heroin 46.6 53.4 88 
    
Methamphetamine 40.8 59.2 265 
    





 Table 6 
  Logistic Regression Analysis of Variables Influencing Treatment Attendance 
Predictor Variable N B Wald d.f. p Odds Ratio 
Block 1: Demographics       
Age 773 .015 3.184 1 .074 1.015 
Sex 773 -.146 .743 1 .392 .864 
Racial Background 773 .115 .265 1 .607 1.122 
Ethnic Background 773 -.250 1.071 1 .301 .779 
       
Block 2: Socioeconomic       
Marital Status 773 .062 .066 1 .798 1.063 
Employment Status 773 -.165 .954 1 .329 .848 
Education Level       
     Less Than High School 217  7.535 3 .057  
     High School or GED 308 .635 2.575 1 .109 1.869 
     Some College or Voc. Training 209 .421 1.237 1 .266 1.524 
     College Graduate or Above 39 .080 .043 1 .835 1.083 
       
Block 3: Frequency of Use       
Frequency of Use       
     1-3 days in past month 148  4.948 4 .293  
     1-2 days in past week 68 -.316 2.190 1 .139 .729 
     3-6 days in past week 81 -.429 2.030 1 .154 .651 
     Daily 113 -.479 2.759 1 .097 .619 




      Dependent Variable= treatment attendance (0= No, 1= Yes) 
***The Ambivalence Scale is reverse-scored and a lower score is preferable. 





       
       
Table 6 continued 
Predictor Variable N B Wald d.f. p Odds Ratio 
Block 4: Referral Source       
Referral Source 773 -.197 1.326 1 .249 .821 
       
Block 5: Interim Group       
Number of Interim Groups       
     1 Group 338  9.124 2 .010*  
     2-4 Groups 231 -.566 8.887 1 .003** .568 
     5 or More Groups 204 -.418 4.325 1 .038* .658 
       
Block 6: SOCRATES Scales       
Recognition 773 .024 2.584 1 .108 1.024 
Ambivalence*** 773 -.039 3.528 1 .060 .962 
Taking Steps 773 .034 4.190 1 .041* 1.035 
 Dependent Variable= treatment attendance (0= No, 1= Yes) 
 ***The Ambivalence Scale is reverse-scored and a lower score is preferable. 












 The purpose of this study was to examine whether drug of choice, demographics, 
Interim Group attendance and the SOCRATES scales predict substance abuse treatment 
attendance.  As previously mentioned, one of the biggest challenges in the substance 
abuse field is that of individuals who have been referred for substance abuse treatment 
not initiating that treatment (Donovan et al., 2001; Weisner et al., 2001).   Numerous 
explanations could be postulated as to why treatment initiation does not occur, and this 
study looked at the predictive value of multiple variables that could influence treatment 
attendance.  One goal of this study was to expand on the study conducted by Ravarino et 
al. (2008), which only looked at individuals seeking treatment for methamphetamine use 
and did not evaluate SOCRATES data. Ravarino et al. found that attending more Interim 
Groups was more predictive of an individual entering substance abuse treatment than 
were demographic variables.  Ravarino et al. did not look at the predictive value of 
different drugs of choice, nor did they evaluate the predictive value of the scales of the 
SOCRATES.  The present study included a larger sample size than that of Ravarino et al. 
and also looked at individuals seeking treatment for alcohol, heroin, cocaine, marijuana 




SOCRATES scales in determining substance abuse treatment entry.  The following 
hypotheses were tested: 
 
Research Question #1:  Will primary drug of choice predict entrance into treatment? 
 Primary drug of choice was not found to be a significant predictor of substance 
abuse treatment attendance.  While not significant, participants’ specifying the various 
primary drugs of choice did demonstrate some differences in their rates of treatment 
attendance.  Compared to participants who specified alcohol as their primary drug of 
choice, participants specifying heroin as their primary drug of choice were slightly more 
likely to attend treatment, as evidenced by their slightly higher percentage of treatment 
attendance when compared with the participants with other primary drugs of choice.  In a 
similar comparison, participants specifying marijuana as their drug of choice were less 
likely to attend treatment than users of other drugs. Literature is supportive of the 
findings in this study, as demonstrated by De Leon et al. (1997), who looked at a sample 
of individuals seeking residential substance abuse treatment and found that there were 
few differences between the various drugs of choice in terms of treatment retention and 
initial motivation and readiness for substance abuse treatment.  These findings, along 
with the findings from the present study, further suggest that drug of choice would not be 
a consistent predictor of treatment attendance, and it is likely that other factors contribute 
to an individual attending treatment.  Furthermore, the present study examined 
individual’s primary drug of choice and did not take into consideration the possibility that 
these individuals could be poly-substance users and may have differing reasons for not 




 One possible alternative explanation for what prompts individuals to initiate 
substance abuse treatment was posited by Pollini, O’Toole, Ford and Bigelow (2006).  
They found that the most frequent reason given for expressing an interest in attending 
substance abuse treatment was that the participants were “tired of using,” suggesting that 
these individuals experienced a subjective desire to move on with their lives and stop 
using substances.  The participants in the study conducted by Pollini et al. specified 
primary drugs of choice similar to those being considered in the present study, suggesting 
that regardless of the primary drug of choice, attitudes about use may be a more 
important predictor of treatment attendance.  In applying these findings to the present 
study, it could be suggested that the majority of the participants in this study were not 
“tired of using” and were therefore not prepared nor motivated to initiate substance abuse 
treatment at this time. 
 
Research Question #2:   Will the SOCRATES scales (Ambivalence, Recognition and 
Taking Steps) be a better predictor of entrance into treatment compared to that of 
demographics or number of Interim Groups attended? 
 Both Interim Group and the SOCRATES were found to be significant, although 
both offer little predictive value about substance abuse treatment attendance.  More 
specifically, the Taking Steps scale of the SOCRATES was found to be significant.  
While both the Interim Group and SOCRATES variables were significant, taking a 
holistic view of the logistic regression statistics into account, neither of these variables 
offered much in predictive value regarding an individual’s substance abuse treatment 




treatment attendance, although some variables approached significance. 
 The demographic results found in this study appear to be consistent with previous 
studies.  The literature indicates that demographic variables are not a good predictor of 
substance abuse treatment attendance, nor can demographic variables offer much 
descriptive value about an individual’s readiness to change (DiClemente et al., 2009; 
Messina, Burdon, Hagopian & Prendergast, 2006; Ravarino et al., 2008).  Additionally, 
Weisner et al. (2009) found that individuals who were mandated to receive substance 
abuse treatment had similar outcomes to those who voluntarily sought treatment.  Similar 
to the findings found by Weisner et al., the results of the present study indicate that 
participants who were legally referred to substance abuse treatment had treatment 
attendance rates that were similar to those who were voluntarily seeking substance abuse 
treatment, and no significant differences were found between the two groups.  
Furthermore, it should be noted that in the present study, participants self-reported if they 
were legally referred, and it is possible that some participants may not have been 
forthcoming with this information, thereby not providing an accurate number of 
participants who were legally referred and who were voluntary. 
 As mentioned above, the number of Interim Groups a participant attended was 
found to be more predictive of their subsequent substance abuse treatment attendance 
than their scores on the three SOCRATES scales.  Interestingly, the findings in the 
current study indicate that the more Interim Groups an individual attends the less likely 
they are to attend substance abuse treatment, which is counter to the results that Ravarino 
et al. (2008) found, in which attending between 5 and 24 groups made it more likely that 




attending one Interim Group was more predictive of substance abuse treatment 
attendance than attending more than one group, although it is important to consider that 
the modal number of Interim Groups attended was one.  These discrepant findings 
between the present study and the study conducted by Ravarino et al. could be due to the 
larger sample size in the present study, as well as the inclusion of participants with 
primary drugs of choice other than just methamphetamine.  Additionally, differences 
exist between the participants in the study by Ravarino et al. and the present study, as 
individuals are now referred to Interim Groups from a wider range of referral sources 
than was the case in the time period that Ravarino et al. considered.  It is possible that 
these varying referral sources influence the accuracy of the information that the 
participants provided, such as if there were legally referred, as well as influencing the 
participants’ motivation to follow through with a treatment referral.  While there is a 
paucity of research and literature on the use of interim interventions and groups, it 
appears that these discrepant findings have larger implications for the use of Interim 
Groups as well as for the broader field of substance abuse and need to be further 
explored. 
 The last noteworthy finding of the present study shows that the Taking Steps scale 
of the SOCRATES was a significant predictor of substance abuse treatment, suggesting 
that the more steps the participant is taking to change their substance use behavior, the 
more likely they are to attend substance abuse treatment.  This finding is consistent with 
the aforementioned drug of choice variable finding that individuals who initiate substance 
abuse treatment are more likely to be ready to stop using their drug of choice (Pollini et 




to change have been inconsistent predictors of substance abuse treatment attendance.  
Applying this finding to the present study, it would suggest that while some participants 
may have reported Taking Steps to change their substance use when they completed their 
initial SOCRATES, this motivation may not be long-lasting, and therefore, not sufficient 
for substance abuse treatment attendance.  Further, participants may have considered 
their initial decision to attend Interim Group as evidence that they are changing their 
substance use behaviors, which is what the Taking Steps scale is supposed to capture.  
DiClemente further expounds that readiness to change substance use behaviors is not the 
same as readiness for substance abuse treatment, implying that some other variable is 
key.  To further elaborate on DiClemente’s explanation, Rapp et al. (2003) suggests that 
problem recognition plays an important role in an individual’s motivation, as individuals 
with more severe substance use problems were found to be more motivated to change 
their substance use behavior.  It could be that the individuals reporting higher scores on 
Taking Steps also had higher scores on the Recognition scale, although the Recognition 
scale was not found to significantly predict substance abuse treatment attendance. 
 Additionally, a study conducted by Fickenscher et al. (2006) found a possible 
explanation for the Taking Steps scale’s significant results in the present study.  
Fickenscher posits that treatment readiness is determined by behaviors of individuals who 
are in the action stage of the stages of change, as evidenced by these individuals making a 
commitment to change their behavior, and ultimately entering a substance abuse 
treatment program.  If the participants in the present study were in the action stage of the 
stages of change model, it is likely they have made a commitment to change their 




attend substance abuse treatment.  It appears that the participants’ subjective views of 
their behavioral changes are important, and if they believe they are making changes, such 
as by attending Interim Group, then they are more likely to stay motivated to attend 
substance abuse treatment. 
 And finally, the participants in the present study sample were relatively low on 
the Ambivalence scale of the SOCRATES, which is indicative of little or no ambivalence 
about changing substance use behaviors.  It is likely that while the three scales of the 
SOCRATES are considered to be independent, the Ambivalence scale is influenced by a 
participant’s scores on the other scales of the SOCRATES.  The sample also appears 
relatively low on the Recognition scale, suggesting participants may be denying that their 
substance use has created problems for them, and they are not expressing a desire to 
change.  This could suggest that participants are low on the Ambivalence scale because 
they do not recognize their substance use as problematic, and they likely feel that they are 
in control of their substance use.  Additionally, Maisto et al. (1999) suggested that the 
Ambivalence factor of the SOCRATES is relatively unstable, which would help to 
explain why it was approaching significance in the present study, although the 
distribution of scores did not seem indicative of why it would be significant.  
Furthermore, it should be noted that Burrow-Sanchez and Lundberg (2007) found a two-
factor model of the SOCRATES, including just the Amrec and Taking Steps scales, to be 
more efficient for the population being considered in the present study.  These findings 
could have implications for the present study, as the present study used the three-factor 
model of scoring the SOCRATES due to the lack of availability of a scoring rubric for 




SOCRATES results in the present study are not as accurate as they could have been had 
results been interpreted with a two-factor model. 
 
Limitations and Future Research 
 The findings in this study should be interpreted with caution, as several 
limitations were evident.  First, due to the self-report nature of the data, it is possible that 
participants did not fully disclose information on some questions, such as questions on 
the demographic form and the SOCRATES pertaining to their current substance use and 
substance use behaviors, suggesting some participants may have minimized their current 
use patterns and behaviors.  Given the nature of how these data were collected, it was 
impossible to corroborate the data.  A replication of this study with the collection of 
collateral information, such as from probation or parole officers, or from other significant 
individuals in the participant’s life, would be beneficial to obtain more objective data.   
 Second, the sample was recruited from a unique population of individuals seeking 
substance abuse treatment in a medium-sized city in a Mountain West State.  These 
individuals are seeking county subsidized substance abuse treatment, and are likely very 
different from individuals who are able to afford substance abuse treatment.  
Consequently, being able to afford substance abuse treatment and not having to wait for 
county funding to be available could have a significant impact on an individual’s 
motivation and follow through with treatment attendance.  Replicating this study in a 
different setting, such as a different geographic location or including individuals who are 
not seeking county subsidized treatment, would be interesting in evaluating if the 




findings can be generalized to all individuals seeking substance abuse treatment. 
  Additionally, due to the variables being considered in this study, it is possible 
that other personal characteristics, such as mental health diagnoses, could have played a 
role in an individual’s decision to enter substance abuse treatment.  The present study did 
not take into consideration previous mental health diagnoses or if the participant had 
previously attended substance abuse treatment, although both of these circumstances 
were addressed on the demographic form that each participant completed.  Future studies 
should give more consideration to additional personal characteristics and background 
information of the participants.  For example, one could postulate that if an individual has 
previously attended substance abuse treatment, this would be a determining factor in their 
decision to attend substance abuse treatment again, particularly given their perceived 
experience in any previous treatment as either positive or negative. 
 And finally, it should be noted that while this study was looking at treatment 
attendance, as evidenced by the participant attending the 1st day of treatment, this does 
not suggest that the participant completed their substance abuse treatment after making an 
initial appearance.  Additionally, the timeframe considered in this study looked at the 
initiation of treatment within 190 days, and it is possible that participants could have 
initiated their substance abuse treatment after that time.  Further, it is possible that 
participants could have initiated substance abuse treatment without utilizing county 
funding, and therefore their treatment attendance would not be captured by this treatment 
attendance data.  Future studies should consider whether or not the participants 
completed the recommended substance abuse treatment once they initiated it.  A 




to take into account the participant’s subjective experiences of either completing 



















STAGES OF CHANGE READINESS AND TREATMENT  
EAGERNESS SCALE (SOCRATES) FORM 
 
    Interim Group Data Sheet 
 
Name:  Day and date___________________ 
 
Date of birth:  Primary drug of choice (present or past):____________ 
 
List other drugs/alcohol in use:        
 
Answer the following on the scale below:  Did you come to Interim Group today by choice? 
 (Circle your response) 
 
  1---------------2---------------3---------------4---------------5 
 Not at all Somewhat Totally   
 
 Is this your first Interim Group?  (circle one)    YES  /  NO  
   
  IF YES – SKIP TO 
SECTION II 
  IF NO – CONTINUE WITH 
SECTION I 
 
SECTION I - ONLY for clients who have come to Interim Groups BEFORE: 
 
  
 How many days has it been   
 since your last Interim Group?   
 
 How many of those days since  
 coming to Interim Group have you  
 USED DRUGS OR ALCOHOL?   
 
 







All Interim clients, whether this is your first time or not, please complete the following 
questionnaire.  There are no right and wrong answers to these questions.  Try to be as 
thoughtful as you can in making your responses.  Use the following scale to indicate how 
much you agree with the statements below.   
 
 
   1---------------2---------------3---------------4---------------5 
 Strongly disagree Disagree   Neutral Agree Strongly agree 
 
 
*1) ______ I really want to make changes in my drinking/drug use.  
 
*2) ______ Sometimes I wonder if I am a drug-addict / alcoholic.  
 
  3) ______ As far as I’m concerned, I don’t have any problems that need changing. 
 
*4) ______ If I don’t change my drinking / drug use soon, my problems are going to 
get worse. 
 
*5) ______ I have already started making some changes in my drug use / drinking.  
 
   
*6) ______ I was using drugs / drinking too much at one time, but I’ve managed to 
change my drug use / drinking.  
 
  7) ______ I’m not the problem one.  It doesn’t make sense for me to be here. 
 
*8) ______ Sometimes I wonder if my drinking / drug use is hurting other people.  
 
*9) ______ I am a problem drug-user / drinker.  
 
 10)______ Being here is pretty much a waste of time for me because the problem 
doesn’t have to do with me. 
 
*11)______ I’m not just thinking about changing my drinking / drug use, I’m already 
doing something about it.  
 
*12)______ I have already changed my drug use / drinking, and I am looking for ways 
to keep from slipping back into my old pattern.  
 
*13)______ I have serious problems with drinking / drug use.  
 





*15)______ Sometimes I wonder if I am in control of my drug use / drinking.  
 
*16)______ My drinking / drug use is causing a lot of harm.  
 
  17)______ I may be part of the problem, but I don’t really think I am. 
 
*18)______ I am actively doing things now to cut down or stop using drugs / drinking.  
 
*19)______ I want help to keep from going back to the drinking / drug use problems 
that I had before.  
 
  20)______ All this talk about psychology is boring.  Why can’t people just forget 
about their problems. 
 
*21)______ I know that I have a drug use / drinking problem.  
 
*22)______ There are times when I wonder if I drink / use drugs too much.  
 
  23) ______ I have worries but so does the next person.  Why spend time thinking 
about them? 
 
*24)______ I am a drug addict / alcoholic.  
 
*25)______ I am working hard to change my drinking / drug use.  
 
*26)______ I have made some changes in my drug use / drinking, and I want some 
help to keep from going back to the way I used to use drugs / drink. 
 
  27) ______ I would rather cope with my faults than try to change them. 
 
 












INTERIM GROUP DEMOGRAPHIC INFORMATION FORM 
 
Interim Group/Recovery Management Services Profile 
 
Please Answer All Questions 
If question does not apply to you please mark “N/A” for “not applicable” 
 
Today’s Date:____________________________________  
 
First Name:____________________________ Middle 
Name:__________________________ 
 
Last Name:______________________________________ Date of 
Birth:______________ 
 




City:________________________ State:___________ Zip 
Code:_________________ 
 
Phone Number:_______________  
What County do you reside in:___________________ 
       
Race (circle one): (I)      Ethnicity (circle one): (J)  
 
1 Alaskan Native     1 Not of Hispanic 
2 American Indian      Origin 
3 Asian       2 Mexican                     
4 Black/African American    3 Puerto Rican 
5 Native Hawaiian/Other Pacific Islander  4 Cuban 
6 White       5 Other Hispanic 








How many years of education have you completed? (circle one) (K) 
 
1 No Schooling   15 High School Diploma (not GED) 
2 Kindergarten   16 Vocational Training beyond H.S. 
3 1st Grade   17 Special Education (ungraded classes)           
4 2nd Grade   18 Baccalaureate Degree (B.S., B.A.)                
5 3rd Grade   19 Graduate work (no degree) 
6 4th Grade   20 Master’s Degree 
7 5th Grade   21 Doctorate/Professional Degree  
8 6th Grade   22 Post Secondary 1 year 
9 7th Grade   23 Post Secondary 2 years (Inc AA degree) 
10 8th Grade   24 Post Secondary 3 years 
11 9th Grade   25 Post Secondary 4 years +  (no degree) 
12 10th Grade   26 Other 




Have you ever been in the military? (L)  ______ Yes (1)   ______ No (2) 
 
 
If you answered “Yes” to military service, circle the one that applies to you: (M) 
 
 1 In Reserves or National Guard; Combat 
 2 In Reserves or National Guard; No Combat 
 3 Military Dependent 
 4 On Active Duty; Combat 
 5 On Active Duty; No Combat 
 6 Retired from Military 
 7 Veteran; Other Eras 
 8 Vietnam Era Veteran; Combat 








What other agencies will need to know you’re attending Interim Group (agency 








Circle your drug of choice: (O) 
Please only choose one, your primary drug of choice, even if you use alcohol and/or 
other drugs.. 
 
1 Alcohol     17 Lorazepam (Ativan) 
2 Cocaine/Crack    18 Clonazepam (Klonopin) 
3 Marijuana/Hashish    19 Alprazolam (Xanax) 
4 Heroin      20 Diazepam (Valium) 
5 Methamphetamine    21 Other Benzodiazepines 
6 Methylphenidate (Ritalin)   22 Other Sedatives 
7 Other Amphetamines    23 PCP 
8 Other Stimulants    24 LSD 
9 Oxycodone (Oxycontin/Percocet)  25 Other Hallucinogens 
10 Hydrocodone (Vicodin/Lortab)  26 MDMA (Ecstasy) 
11 Morphine (MS/Contin)   27 Rohypnol 
12 Non-prescription methadone   28 GHB/GBL 
13 Other Opiates     29 Ketamine (Special K) 
14 Barbiturates     30 Over the Counter 
15 Other Tranquilizers    31 Other 
16 Inhalants     32 Unknown 
 
Have you ever used a needle to administer drugs? (P) ______ Yes (1)   ______ No (2) 
 
Are you pregnant? (circle one)  Are you HIV positive? (circle one)  
 1 Yes    1 Yes 
 2 No    2 No 
 3 Unknown   3 Never been tested 
 4 Does not apply (circle for 
all males) 
 
PLEASE NOTE: The following information is NOT provided to treatment agencies, 
parole/probation officers or any other entities.  This information is used for 
Program Evaluation Purposes, 
 
1.) How many times have you been in a substance abuse treatment program? (S) 
________ 
Include all prior treatments even if you did not complete the program; do not include 
support groups such as AA, NA or Interim Group. 
  
2.) Have you ever been diagnosed with a psychological/emotional problem? (T)  
_________Yes (1)  _________No (2) 
 
3.) Are you currently taking any medications specifically for the treatment of a 





4.) How many children do you have? (V)  ___________________ 
Include all you children even if you do not currently have custody of them. 
 
5.) Are your children currently living with you? (W) 
Only include minor children (children under the age of 18). 
 
_____Yes (1) ______ No (2)  ______ Some of them (3)  
   
6.) How many times have you been arrested in the last six months? (X) 
________________ 
 
7.) What is your current marital status? (Y) 8.) What is your employment 
status? (Z) 
(circle one)     (circle one) 
 
 1 Married    1 Employed Full Time 
 2 Never Married    2 Employed Part Time 
 3 Separated    3 Unemployed 
 4 Divorced    4 Homemaker 
 5 Widowed    5 Student 
 6 Unknown    6 Disabled 
       7 Other 
 
9.) If you are currently unemployed, how many MONTHS have you been 
unemployed? (AA) ________ 
 
10.) At what age did you first use the drug of choice you listed above? (AB) 
____________ 
 
11.) How do you usually administer (use)  12.) How often have you used your drug  
the drug of choice you listed above? (AC) of choice in the past 30 days? (AD) 
(circle one)     (circle one) 
 
 1 Oral (Swallowed)   1 1-3 days in the past month 
 2 Smoking    2 1-2 days per week 
 3 Nasal (Snorted, Sniffed)  3 3-6 days per week 
 4 IV Injection    4 Daily 
 5 Inhalation (Fumes)   5 No use in the past month 
 
13.) How many years have you been using your drug of choice? (AE) 
______________ 
 
14.) Do you have a second drug of choice? (AF) 
____________________________________ 
Refer to the list above and write in your answer.  If you do not have a second drug, skip 





15.) At what age did you first use you second drug of choice? (AG) 
____________________ 
 




17.) Circle how you usually use your  18.) Circle how often you used 
your  second drug of choice:  (AI)    second drug of choice in the past 
30 days?        (AJ) 
       
 1 Oral (Swallowed)   1 1-3 days in the past month 
 2 Smoking    2 1-2 days per week 
 3 Nasal (Snorted, Sniffed)  3 3-6 days per week 
 4 IV Injection    4 Daily 
 5 Inhalation (Fumes)   5 No use in the past month 
 
 
19.) Circle your current living situation: 20.) Circle your current health insurance 
 (AK) status: (AL) 
 
 1 Homeless (shelter, street)  1 Blue Cross/Blue Shield 
 2 Dependent (not paying rent)  2 Medicare 
 3 Independent     3 Medicaid 
 4 Unknown    4 HMO (for example, IHC) 
       5 Other 
       6 None 
 
21.)What is the age that you first ever used any alcohol or drugs? (AM) 
_______________ 
 
22.) Are you currently participating in any other support groups?  
For example, AA, NA etc.     ______ Yes (1) ______
 No (2) 
 
23.) Do you use tobacco?     ________Yes (1) _________ No (2) 
 
24.) If you have used tobacco, at what age did you first use tobacco? 
__________________ 
 
25.)  If you have used tobacco, circle the number which best describes your tobacco 
use: 
  
1. Have used/Not current user 




3. Regular User (less than two packs a day) 
4. Heavy User (two or more packs a day) 




Questions 26 and 27 are for females only 
 
 
26.) Have you ever had a miscarriage? (AO)__________Yes (1) ___________No (2) 
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